Inactivation of Hantaan virus-containing samples for subsequent investigations outside biosafety level 3 facilities
- PMID: 15920350
- DOI: 10.1159/000084603
Inactivation of Hantaan virus-containing samples for subsequent investigations outside biosafety level 3 facilities
Abstract
Objectives: The potential risk of accidental infection by hantaviruses in a clinical or research laboratory necessitates special precautionary measures. A biosafety program must address handling and disposal of infectious materials as well as appropriate virus inactivation or depletion procedures to permit necessary further processing of specimens outside the biosafety level 3 laboratory.
Methods: To study the elimination of hantavirus infectivity, the effects of different chemical and physical inactivation and depletion procedures were investigated on Hantaan virus-containing materials. An infectivity assay for hantaviruses was utilised to verify these procedures which are commonly preceding investigations such as ELISA, flow cytometry analysis, Western blot or immunofluorescence assay.
Results: Chemical inactivation with methanol, paraformaldehyde, acetone/methanol and detergent-containing lysis buffer as well as physical forces such as UV irradiation and filtration efficiently reduced viral infectivity in infected cells and their supernatants below the detection limit.
Conclusion: The virus inactivation and depletion methods described herein are suitable to prepare non-infectious samples for further use in immunological, virological and cell-biological assays.
Copyright (c) 2005 S. Karger AG, Basel.
Similar articles
-
Ultraviolet Inactivation of Chikungunya Virus.Intervirology. 2018;61(1):36-41. doi: 10.1159/000490567. Epub 2018 Jul 26. Intervirology. 2018. PMID: 30048981
-
In-Cell Western Assays to Evaluate Hantaan Virus Replication as a Novel Approach to Screen Antiviral Molecules and Detect Neutralizing Antibody Titers.Front Cell Infect Microbiol. 2017 Jun 20;7:269. doi: 10.3389/fcimb.2017.00269. eCollection 2017. Front Cell Infect Microbiol. 2017. PMID: 28676847 Free PMC article.
-
Development and Testing of a Method for Validating Chemical Inactivation of Ebola Virus.Viruses. 2018 Mar 13;10(3):126. doi: 10.3390/v10030126. Viruses. 2018. PMID: 29533988 Free PMC article.
-
Isolation of a strain of a Hantaan virus from a fatal case of hemorrhagic fever with renal syndrome in Slovenia.Am J Trop Med Hyg. 1994 Oct;51(4):393-400. Am J Trop Med Hyg. 1994. PMID: 7943563
-
Epidemiological progresses of hemorrhagic fever with renal syndrome in China.Chin Med J (Engl). 1999 May;112(5):472-7. Chin Med J (Engl). 1999. PMID: 11593522 Review.
Cited by
-
In Search for Factors that Drive Hantavirus Epidemics.Front Physiol. 2012 Jul 10;3:237. doi: 10.3389/fphys.2012.00237. eCollection 2012. Front Physiol. 2012. PMID: 22934002 Free PMC article.
-
Methods of Inactivation of Highly Pathogenic Viruses for Molecular, Serology or Vaccine Development Purposes.Pathogens. 2022 Feb 19;11(2):271. doi: 10.3390/pathogens11020271. Pathogens. 2022. PMID: 35215213 Free PMC article. Review.
-
Seoul virus suppresses NF-kappaB-mediated inflammatory responses of antigen presenting cells from Norway rats.Virology. 2010 Apr 25;400(1):115-27. doi: 10.1016/j.virol.2010.01.027. Epub 2010 Feb 18. Virology. 2010. PMID: 20170933 Free PMC article.
-
Puumala and Tula Virus Differ in Replication Kinetics and Innate Immune Stimulation in Human Endothelial Cells and Macrophages.Viruses. 2019 Sep 14;11(9):855. doi: 10.3390/v11090855. Viruses. 2019. PMID: 31540120 Free PMC article.
-
Dobrava-Belgrade hantavirus from Germany shows receptor usage and innate immunity induction consistent with the pathogenicity of the virus in humans.PLoS One. 2012;7(4):e35587. doi: 10.1371/journal.pone.0035587. Epub 2012 Apr 24. PLoS One. 2012. PMID: 22545121 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources